EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Pedja Kovacevic, Dragana Milakovic, Tijana Kovacevic, Vedrana Barisic, Sasa Dragic, Biljana Zlojutro, Branislava Miljkovic, Katarina Vucicevic, Zeeshan Rizwan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03136-1 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Pedja Kovacevic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Intensive Care Unit, University Clinical Centre of the Republic of Srpska, Dvanaest Beba Bb, 78000, Banja Luka, The Republic of Srpska, Bosni…. Hauptthemen laut MEDLINE: Linezolid, Thrombocytopenia, Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidThrombocytopeniaRespiratory Distress SyndromeExtracorporeal Membrane OxygenationHumansMaleFemaleMiddle AgedProspective StudiesAgedAnti-Bacterial AgentsCOVID-19COVID-19 Drug TreatmentAdult

Stichwörter der Autor:innen

ARDSDosing regimeECMOLinezolidSafetyThrombocytopenia

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Intensive Care Unit, University Clinical Centre of the Republic of Srpska, Dvanaest Beba Bb, 78000, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina. pedja.kovacevic@med.unibl.org.
  • Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Herzegovina. pedja.kovacevic@med.unibl.org.
  • Medical Intensive Care Unit, University Clinical Centre of the Republic of Srpska, Dvanaest Beba Bb, 78000, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
  • Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Herzegovina.
  • Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade Faculty of Pharmacy, Vojvode Stepe 40, 11221, Belgrade, Republic of Serbia.
  • Department of Pharmacy, Mayo Clinic, Rochester, USA.

Zitieren

APA

Kovacevic, P., Milakovic, D., Kovacevic, T., Barisic, V., Dragic, S., Zlojutro, B., Miljkovic, B., Vucicevic, K., & Rizwan, Z. (2024). Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03136-1

Vancouver

Kovacevic P, Milakovic D, Kovacevic T, Barisic V, Dragic S, Zlojutro B, et al. Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03136-1

BibTeX
@article{Kovacevic2024,
  author = {Kovacevic, Pedja and Milakovic, Dragana and Kovacevic, Tijana and Barisic, Vedrana and Dragic, Sasa and Zlojutro, Biljana and Miljkovic, Branislava and Vucicevic, Katarina and Rizwan, Zeeshan},
  title = {Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03136-1}
}
Kostenlos starten →